HUBB:NYSEHubbell Inc Analysis
Data as of 2026-03-10 - not real-time
$489.25
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hubbell delivered Q4 revenue of $1.49 billion, up 11.9% YoY, and posted non‑GAAP earnings of $4.73 per share, matching consensus estimates. The company’s profit margin of 15.2% and operating margin of 19.1% underline solid profitability, while a ROE of 24.5% signals efficient capital use. With a dividend yield of 1.16% and a payout ratio near 32%, the dividend appears sustainable given strong operating cash flow of $1.03 billion.
Technical signals are mixed: the stock trades below its 20‑day SMA (509) but above the 50‑day SMA (491), and the MACD is bearish, while volume is trending down. The market price of $489 is well above the DCF‑derived fair value of $255, suggesting the stock is currently overvalued despite an analyst median target of $545 and modest upside of ~8‑10%.
Technical signals are mixed: the stock trades below its 20‑day SMA (509) but above the 50‑day SMA (491), and the MACD is bearish, while volume is trending down. The market price of $489 is well above the DCF‑derived fair value of $255, suggesting the stock is currently overvalued despite an analyst median target of $545 and modest upside of ~8‑10%.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram indicating near‑term downside pressure
- Decreasing volume trend reducing short‑term momentum
- Price positioned just above the identified support level at $457.6
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 11.9% and strong ROE of 24.5% supporting earnings expansion
- Analyst median price target of $545 implying ~11% upside
- Sustainable dividend with a low payout ratio and solid cash flow generation
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Long‑term demand for grid modernization and utility infrastructure
- High valuation multiples relative to DCF fair value
- Moderate leverage (Debt/Equity 64%) and ample cash to service debt
Key Metrics & Analysis
Financial Health
Revenue Growth11.90%
Profit Margin15.18%
P/E Ratio29.6
ROE24.54%
ROA10.03%
Debt/Equity64.47
P/B Ratio6.8
Op. Cash Flow$1.0B
Free Cash Flow$680.9M
Industry P/E29.8
Technical Analysis
TrendBullish
RSI45.3
Support$457.60
Resistance$533.80
MA 20$509.39
MA 50$490.91
MA 200$442.91
MACDBearish
VolumeDecreasing
Fear & Greed Index80.41
Valuation
Fair Value$255.20
Target Price$532.85
Upside/Downside8.91%
GradeOvervalued
TypeBlend
Dividend Yield1.16%
Risk Assessment
Beta1.12
Volatility31.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.